【レポートの概要（一部）】
Table of Content
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
1.3 Country Wise Market Calculation
1.3.1 Country wise market: Base estimates
1.3.2 Global market: CAGR calculation
1.4 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot, 2016 (USD Million)
Chapter 3 Oncology in-vivo CRO Market Variables, Trends, & Scope
3.1 Market Segmentation & Scope
3.2 Market Size And Growth Prospects
3.3 Market Driver Analysis
3.3.1 Focus on core competencies by the pharmaceutical players
3.3.2 Accelerating time to market
3.4 Market Restraint Analysis
3.5 Key Opportunities Prioritized
3.6 Industry Analysis Porter’s
3.7 Oncology based in-vivo CRO PESTEL Analysis
Chapter 4 Oncology in-vivo CRO Market: Indication Estimates & Trend Analysis
4.1 Oncology in-vivo CRO Market: Indication Movement Analysis
4.2 Blood cancer
4.2.1 Blood cancer market estimates and forecasts, 2014 – 2025 (USD Million)
4.3 Solid tumors
4.3.1 Solid tumors market estimates and forecasts, 2014 – 2025 (USD Million)
4.3.1.1 Syngeneic model based solid tumor market estimates and forecasts, 2014 – 2025 (USD Million)
4.3.1.2 PDX based solid tumor market estimates and forecasts, 2014 – 2025 (USD Million)
4.3.1.3 Xenograft based solid tumor market estimates and forecasts, 2014 – 2025 (USD Million)
4.4 Other
4.4.1 Other market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 5 Oncology in-vivo CRO Market: Regional Estimates & Trend Analysis, by Indication
5.1 Oncology in-vivo CRO Market Share by Region, 2016 & 2025
5.2 North America
5.2.1 Oncology in-vivo CRO market estimates and forecasts, 2014 – 2025
5.2.2 U.S.
5.2.2.1 Oncology in-vivo CRO market estimates and forecasts, by indication, 2014 – 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Oncology in-vivo CRO market estimates and forecasts, by indication, 2014 – 2025 (USD Million)
5.3 Europe
5.3.1 Oncology in-vivo CRO market estimates and forecasts, 2014 – 2025
5.3.2 UK
5.3.2.1 Oncology in-vivo CRO market estimates and forecasts, by indication, 2014 – 2025 (USD Million)
5.3.3 Germany
5.3.3.1 Oncology in-vivo CRO market estimates and forecasts, by indication, 2014 – 2025 (USD Million)
5.4 Asia Pacific
5.4.1 Oncology in-vivo CRO market estimates and forecasts, 2014 – 2025
5.4.2 Japan
5.4.2.1 Oncology in-vivo CRO market estimates and forecasts, by indication, 2014 – 2025 (USD Million)
5.4.3 China
5.4.3.1 Oncology in-vivo CRO market estimates and forecasts, by indication, 2014 – 2025 (USD Million)
5.5 Latin America
5.5.1 Oncology in-vivo CRO market estimates and forecasts, 2014 – 2025
5.5.2 Brazil
5.5.2.1 Oncology in-vivo CRO market estimates and forecasts, by indication, 2014 – 2025 (USD Million)
5.5.3 Argentina
5.5.3.1 Oncology in-vivo CRO market estimates and forecasts, by indication, 2014 – 2025 (USD Million)
5.6 MEA
5.6.1 Oncology in-vivo CRO market estimates and forecasts, 2014 – 2025
5.6.2 South Africa
5.6.2.1 Oncology in-vivo CRO market estimates and forecasts, by indication, 2014 – 2025 (USD Million)
5.6.3 Saudi Arabia
5.6.3.1 Oncology in-vivo CRO market estimates and forecasts, by indication, 2014 – 2025 (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Company Profiles
6.2.1 Charles River Laboratory (CRL)
6.2.1.1 Company overview
6.2.1.2 Financial performance
6.2.1.3 Product benchmarking
6.2.1.4 Strategic initiatives
6.2.2 ICON Plc
6.2.2.1 Company overview
6.2.2.2 Financial performance
6.2.2.3 Product benchmarking
6.2.2.4 Strategic initiatives
6.2.3 Covance
6.2.3.1 Company overview
6.2.3.2 Financial performance
6.2.3.3 Service benchmarking
6.2.3.4 Strategic initiatives
6.2.4 Eurofins Scientific
6.2.4.1 Company overview
6.2.4.2 Financial performance
6.2.4.3 Product benchmarking
6.2.4.4 Strategic initiatives
6.2.5 Taconic Biosciences
6.2.5.1 Company overview
6.2.5.2 Financial performance
6.2.5.3 Product benchmarking
6.2.5.4 Strategic initiatives
6.2.6 Crown Bioscience
6.2.6.1 Company overview
6.2.6.2 Financial performance
6.2.6.3 Product benchmarking
6.2.6.4 Strategic initiatives
6.2.7 Toxikon, Inc.
6.2.7.1 Company overview
6.2.7.2 Financial performance
6.2.7.3 Product benchmarking
6.2.7.4 Strategic initiatives
6.2.8 WuXi AppTec
6.2.8.1 Company overview
6.2.8.2 Financial performance
6.2.8.3 Product benchmarking
6.2.8.4 Strategic Initiatives
6.2.9 EVOTEC
6.2.9.1 Company overview
6.2.9.2 Financial performance
6.2.9.3 Product benchmarking
6.2.9.4 Strategic initiatives
6.2.10 The Jackson Laboratory
6.2.10.1 Company overview
6.2.10.2 Financial performance
6.2.10.3 Product benchmarking
6.2.10.4 Strategic initiatives
【レポート販売概要】
■ タイトル：腫瘍学に基づくインビボCROの世界市場分析：指示別（血液がん、固形腫瘍）、モデル別（同系モデル、患者由来異種移植片（PDX）、異種移植片）、地域別、セグメント予測、2014-2025■ 英文：Oncology Based In-vivo CRO Market Analysis By Indication (Blood cancer, Solid tumor), By Model (Syngeneic model, Patient Derived Xenograft (PDX), Xenograft), By Region, And Segment Forecasts, 2014-2025
■ 発行日：2017年5月26日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707611
■ 調査対象地域：グローバル
- アレルギー性鼻炎(Allergic Rhinitis)の治療薬パイプライン動向（2015年上半期版）Allergic Rhinitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Allergic Rhinitis - Pipeline Review, H1 2015’, provides an overview of the Allergic Rhinitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism …
- 熱成形プラスチックの世界市場2016-2020About Thermoformed Plastic Products Thermoformed plastic products are produced in bulk by heating a plastic sheet to bendable form, shaping it into the required design, and then cooling it. The cooled product is trimmed to get the required usable end-product. Technavio’s analysts forecast the global thermoformed plastics market to grow at a CAGR of 4.87% during the period 2016-2020. [Covered in th …
- ライフサイエンス及び化学分析機器の世界市場：クロマトグラフィー装置、電気泳動、DNAシークエンサー、PCR、マイクロプレートリーダー等The global life science and chemical instrumentation market is estimated to grow at a CAGR of 6.9% from 2014 to 2019. Although mature markets (such as the U.S., Germany, France, and the U.K.) held larger shares in the global life science and chemical instrumentation market in 2014, the Asia-Pacific region is poised to grow at the highest rate in the next five years. Factors such as strategic expan …
- 腹膜がん(Peritoneal Cancer)の治療薬パイプライン動向（2015年上半期版）Peritoneal Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H1 2015’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Peritoneal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism …
- N-メチル-2-ピロリドン（NMP）の世界市場分析：製品別（石油・ガス[ブタジエン回収、BTX抽出]、医薬品[溶剤、浸透増強剤]、電子、塗料・コーティング、農薬）、地域別、セグメント予測、2013 – 2025The global n-methyl-2-pyrrolidone (NMP) market is expected to reach USD 1.79 billion by 2025, according to a new report by Grand View Research, Inc. The NMP market is expected to witness significant growth over the forecast period owing to the increasing demand from Asia Pacific region. NMP is used in a various applications including oil & gas, pharmaceutical, electronics, paints & coatings, agroc …
- 有機酸の世界市場：酢酸、クエン酸、ギ酸、乳酸、プロピオン酸、フマル酸、アスコルビン酸、グルコン酸The organic acids market size is projected to reach USD 9.29 Billion by 2021, at a CAGR of around 6.0% from 2016 to 2021. The market is driven by its wide areas of application and R&D investments and technological innovations such as micro-encapsulation. The significant growth of the F&B industry and organic acids’ functionalities across various industries have also been driving the global organic …
- 日本の心臓人工弁市場見通し（～2021）Japan Prosthetic Heart Valve Procedures Outlook to 2021 Summary GlobalData’s new report, "Japan Prosthetic Heart Valve Procedures Outlook to 2021", provides key procedures data on the Japan Prosthetic Heart Valve Procedures. The report provides procedure volumes within market segments - Conventional Aortic Valve Replacement Procedures, Conventional Mitral Valve Procedures and Transcatheter Heart V …
- 医用画像解析ソフトウェアの世界市場：タイプ別（スタンドアロン）、画像タイプ別（2D、3D、4D）、モダリティ別（CT、MRI、PET、超音波）、用途別（整形外科、歯科、腫瘍、腎臓疾患）、エンドユーザー別（病院、診断センター、研究）、地域別予測Global Medical image software analysis Market to reach USD 4.9 billion by 2025. Global Medical image software analysis Market valued approximately USD 2.41 billion in 2016 is anticipated to grow with a healthy growth rate of more than 8.1% over the forecast period 2017-2025. Key success factors for this market are; technological advancements in medical imaging systems & analysis software, growing …
- 商業用航空機非常用発電機の世界市場2019-2023About this market The increasing electric architecture in modern aircraft will drive the commercial aircraft emergency generators market growth in the forthcoming years. Advances in making aircraft more electric are paying dividends in terms of reduced wiring. Furthermore, the development of electric aircraft systems is showing significant improvements in RATs. Therefore, market vendors are focusi …
- 冠動脈ステントのグローバル新興国市場（2012-2018）BRICSS Coronary Stents market value is expected to reach US$1 billion by 2016, primarily supported by the product types - Drug Eluting Stents, Bare Metal Stents, Absorbable Stents and …etc. China accounts for nearly 28% of the market share and India claims more than 23%. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind. Among the product types, Drug …
- フィブリノゲン欠乏症(Fibrinogen Deficiency)：治療薬開発パイプライン動向（2015年上半期版）Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H1 2015’, provides an overview of the Fibrinogen Deficiency (Factor I Deficiency)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Fibrinogen Deficiency (Factor I Deficiency), …
- Quad 2 (HIV)：市場予測と分析（～2022）Quad 2 (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Quad 2 (HIV) - Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS from a deadl …
- クラウド基盤のソーシャルビジネスサービス市場と分析2013-2018（Social Business Services in the Cloud: Market and Forecast Analysis 2013-2018）Enterprise organizations are challenged with adopting optimized social business practices while integrating global teams, driving innovation, and increased productivity. The promise of Social Business Services in the Cloud is to transform customer information into a competitive advantage through a combination of insights and real-time customer experience/perceptions. Actionable information is deri …
- 高性能計算の世界市場2015-2022According to Stratistics MRC, the Global High Performance Computing market is accounted for $30.64 billion in 2015 and is expected to reach $47.44 billion by 2022 growing at a CAGR of 6.4%. High Performance Computing market is nowadays being linked to technological advancements and economic competitiveness, which are helping the market to compete across the globe. These advancements in computing t …
- 血餅/血栓管理デバイスの世界市場2015-2019About clot management devices A blood clot or thrombus is the end stage of blood coagulation process in hemostasis. Blood clot is the body's response to an injury to prevent bleeding. However, a clot can be harmful when it forms abnormally to obstruct blood flow through healthy blood vessels. This condition is called thrombosis. A blood clot in arteries can lead to heart attack, while blood clot f …
